The drugmaker’s total revenue from operations in the second quarter of current fiscal rose 16.5 per cent to ₹8,016 crore.
Dr Reddy's Laboratories is recalling over 3.3 lakh bottles of Cinacalcet tablets, a medication used for treatment of high ...
The U.S. unit of Indian drugmaker Dr. Reddy’s Laboratories is recalling 331,590 bottles of cinacalcet tablets used to treat hyperparathyroidism due to the presence of a known carcinogen. | The U.S.
Stocks to watch on Monday, November 4, 2024: Indian bourses are preparing for a negative start on Monday, indicated GIFT ...
According to the latest Enforcement Report by the US Food and Drug Administration, Dr Reddy's is recalling the 3,31,590 ...
Dr Reddy's Laboratories has announced a major recall of over 3.3 lakh bottles of Cinacalcet tablets in the United States, citing manufacturing issues. The US Food and Drug Administration stated that ...
The latest Enforcement Report by the US Food and Drug Administration said that Dr Reddy’s is recalling the 3,31,590 bottles ...
The recall is due to the 'presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit', it added.
Dr Reddy’s Laboratories has announced a recall of more than 3.31 lakh bottles of Cinacalcet tablets sold in the US. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback